01 12BOEHRINGER INGELHEIM
01 1212364700
01 12Blank
01 12Blank
01 122037-06-08
Patent Expiration Date : 2037-06-08
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 208026
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 206073
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 201280
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 212614
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 208026
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 212614
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
Patent Expiration Date : 2037-06-08
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 12364700
Drug Substance Claim :
Drug Product Claim :
Application Number : 212614
Patent Use Code : U-4224
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-06-08
